The impact of elective cardioversion for atrial fibrillation in heart failure patients

Back

ESC Premium Access

The impact of elective cardioversion for atrial fibrillation in heart failure patients

Session: Poster Session 4 - Epidemiology of atrial fibrillation, miscellaneous

Topic: Multidisciplinary Interventions

Speaker: Doctor J. Graby (Bath, GB)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor John Graby

Royal United Hospital Bath NHS Trust, Bath (United Kingdom of Great Britain & Northern Ireland)

1 presentation

0 follower

9 more presentations in this session

Circulating biomarkers of myocardial fibrosis and cellular apoptosis in patients with atrial fibrillation and heart failure with preserved ejection fraction

Speaker: Associate Professor M. Dzeshka (Grodno, BY)

Access

Abstract

Slides

Left ventricular stiffness assessed by diastolic wall strain predicts infrequent atrial fibrillation

Speaker: Doctor H. Kishima (Nishinomiya, JP)

Access

Abstract

Slides

Outcomes of heart failure with reduced ejection fraction (HFrEF) status post implantable cardioverter-defibrillator (ICD) presenting with HFrEF exacerbation with verses without atrial fibrillation(AF)

Speaker: Doctor H. Arshad (Newark, US)

Access

Spironolactone in patients with permanent atrial fibrillation, possible heart failure protective potential.

Speaker: Professor R. Dabrowski (Warsaw, PL)

Access

Abstract

Slides

MOODS: a novel risk score to identify patients with atrial fibrillation and sleep apnoea

Speaker: Doctor K. Kadhim (Adelaide, AU)

Access

Abstract

Slides

Access the full session

Poster Session 4 - Epidemiology of atrial fibrillation, miscellaneous

Speakers: Doctor J. Graby, Associate Professor M. Dzeshka, Doctor H. Kishima, Doctor H. Arshad, Professor R. Dabrowski...

Access

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources